Radial Shockwave Versus Low Level Laser Therapy in Patients With Chronic Piriformis Muscle Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-50
SponsorCairo University

About this trial

The study aims to compare the effects of radiation shockwave and low-level laser therapy on piriformis muscle thickness, lower extremity function, pain intensity, and hip range of motion in patients with piriformis syndrome.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Sixty patients' males and females with piriformis syndrome

Their age will range from 30-50 years old

Body mass index will be 25 to 30 (kg/m²).

Both males and females.

Disqualifiers

Lumbo-sacral disc lesion and spinal stenosis.

Lumbar spondylolisthesis.

Pregnancy

Recent fracture and surgery of spine, hip, knee and Ankle.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Conventional treatment

    Other intervention

    Physical therapy can be beneficial for patients with piriformis syndrome, including stretching exercises, local massage, and superficial heat. Traditional stretching techniques include external rotation, hip flexion, and adduction. A hot pack on the trigger point area for 10 minutes followed by passive stretching for 30 seconds each.

  • shockwave therapy

    Device

    Shockwave therapy is a non-invasive alternative treatment for muscle disorders like sports and traumatic injuries, as it reduces pain and promotes soft tissue repair. In a study, patients in group A were treated with three sessions of Storz Medical Shock Wave MP100, each consisting of 2000 pulses with a total energy dose of 1080 mJ / mm. The study aimed to determine the location of the piriformis muscle in the prone position.

  • low level laser therapy

    Device

    Low Level Laser Therapy, also known as Photo-biomodulation, is a low-intensity light therapy that triggers biochemical changes within cells, similar to photosynthesis in plants. It can treat nociceptive and neuropathic pain, but central pain has not been proven responsive to low level laser therapy.

Treatment groups

63 Participants
are divided into 3 treatment groups
Group A: conventional programActive comparator 1 intervention
Group B: Radial Extracorporeal shock waveExperimental treatment 2 interventions
Group C: low level laser therapyExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Assessing the change of body mass index

Weight and height Scale will be used to measure body mass index

Time frame
at baseline and after 6 weeks
2

assessing the change of pain intensity

The 10-cm visual analogue scale has been proven reliable, valid, and responsive for assessing pain levels, with 0 indicating no pain and 10 indicating the worst pain possible, demonstrating its effectiveness in measuring pain.

Time frame
at baseline and after 6 weeks

Secondary outcomes

1

assessing the change of functional status

The patient's functional status is assessed using the Lower Extremity Functional Scale before treatment. This self-assessment tool is valid and reliable, and the patient's score on the questionnaire is evaluated. The scale is free for clinical or research purposes.

Time frame
at baseline and after 6 weeks
2

assessing the change of range of motion of lower limb

Goniometer measurement is used to assess the range of motion of hip internal and external rotation before and after intervention. This simple test is accurate and reliable in detecting changes in hip range of motion, making it a valid measure to detect underlying hip pathology and enable surgical intervention based on it.

Time frame
at baseline and after 6 weeks
3

assessing the change of piriformis muscle thickness

Ultrasound guided measurement for piriformis M.sc thickness may be a reliable technique for early diagnosis of post-operative pain syndrome, increasing conservative treatment options and routinely evaluating patients with unidentified causes of buttock pain. The technique involves placing a probe in the patient's prone position, moving the patient's lower leg to confirm the piriformis position, and measuring piriformis thickness in the medial part of the ischium.

Time frame
at baseline and after 6 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: